Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia

NCT02050854 · clinicaltrials.gov ↗

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar 1 Disorder
Schizophrenia
Mental Disorder
Nervous System Disorders

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.